EKR Therapeutics Inc.

Otonomy, a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for diseases and disorders of the inner and middle ear, has named Anthony J Yost ch

Cornerstone Therapeutics formed a special committee with five independent directors to develop a response to the Cary, North Carolina-based company's largest shareholder – the Chiesi Group of Parma, I

Italy’s Chiesi Farmaceutici SPA is in the market to acquire the remainder of Cornerstone Therapeutics Inc. that it doesn’t already own, according to a letter disclosed in an SEC filing by the

Cornerstone Therapeutics' stock price ticked slightly higher on 8 November, but closed down 0.6% on news that the Cary, North Carolina-based company licensed exclusive US rights to Chiesi Farmaceutici